Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li(Duke University), Jiaoti Huang(Duke University)
Cited by 136
Related Papers
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
|Molecular Cancer|2019|120
All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy
|BMC Complementary and Alternative Medicine|2016|60